This Research Topic is the second volume of the “Unraveling Breast Cancer Complexity: Insights from Single-Cell Sequencing and Spatial Transcriptomics” ...
Pharmaceutical companies are shifting from the development of autologous cell therapies to allogeneic cell therapies.
John M. Archibald is in the Department of Biochemistry and Molecular Biology, Dalhousie University, Halifax, Nova Scotia B3H 4H7, Canada, and also at the Institute for Comparative Genomics, Dalhousie ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results